Launch of the Cleveland Clinic CHIP Clinic: Applying Genomic Discovery to Cardiology
Krishna Aragam, Director of Cardiovascular Genomics at Cleveland Clinic, reposted Ohad Oren’s post on LinkedIn:
“Great to see the launch of the Cleveland Clinic Clonal Hematopoiesis of Indeterminate Potential (CHIP) Cardiology Clinic, a new frontier for applying genomic discoveries to cardiovascular medicine.
CHIP represents a powerful example of how genomic variation — in this case somatic (acquired later in life) rather than germline (inherited at birth) — can inform personalized cardiovascular risk and management.
Looking forward to working with Ohad Oren, MD, MPH and the team to advance precision cardiovascular care guided by genomic insights at the Cleveland Clinic Heart, Vascular and Thoracic Institute.”
Quoting Ohad Oren’s post:
“Launching the Cleveland Clinic CHIP Cardiology Clinic, an exciting step toward integrating clonal hematopoiesis into cardiovascular care.
Excited to share my Circulation paper with Dr. Peter Libby, outlining our vision for the growth and development of CHIP Cardiology programs”
Title: Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice
Authors: Ohad Oren, Peter Libby

Stay informed with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
